                         SEQUENCE LISTING

<110>  Silo Pharma, Inc.
       Weisblum, Eric
 
<120>  CENTRAL NERVOUS SYSTEM DELIVERY OF NONSTEROIDAL ANTI-INFLAMMATORY
        DRUGS AND PSILOCYBIN

<130>  72GJ-319203-WO

<150>  63/060577
<151>  2020-08-03

<160>  22    

<170>  PatentIn version 3.5

<210>  1
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  peptide

<400>  1

Lys Arg Ser Ser 
1               


<210>  2
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  peptide

<400>  2

Pro Gly Glu Ser Ser 
1               5   


<210>  3
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  peptide

<400>  3

Ser Leu Thr Gln 
1               


<210>  4
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  peptide

<400>  4

Ala Met Gly Asn 
1               


<210>  5
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  peptide

<400>  5

Gly Asp Arg Leu Val 
1               5   


<210>  6
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  peptide

<400>  6

Arg Gly Gly Lys Arg Ser Ser 
1               5           


<210>  7
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  peptide

<400>  7

Ser Leu Thr Gln Asp Gln Gly 
1               5           


<210>  8
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  peptide

<400>  8

Ala Asp Ala Gln Ala Asp Val 
1               5           


<210>  9
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  peptide

<400>  9

Arg Ala Lys Gly Arg Asp Ala 
1               5           


<210>  10
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  peptide

<400>  10

Lys Ala Ser Arg Leu Gly Arg 
1               5           


<210>  11
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  peptide

<400>  11

Arg Gly Ala Ser Met Asp Gly 
1               5           


<210>  12
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  peptide

<400>  12

Gly Arg Pro Gly Glu Ser Ser 
1               5           


<210>  13
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  peptide

<400>  13

Ser Arg Thr Glu Gly Asp Val 
1               5           


<210>  14
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  peptide

<400>  14

Cys Arg Gly Gly Lys Arg Ser Ser Cys 
1               5                   


<210>  15
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  peptide

<400>  15

Cys Ser Leu Thr Gln Asp Gln Gly Cys 
1               5                   


<210>  16
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  peptide

<400>  16

Cys Ala Asp Ala Gln Ala Asp Val Cys 
1               5                   


<210>  17
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  peptide

<400>  17

Cys Arg Ala Lys Gly Arg Asp Ala Cys 
1               5                   


<210>  18
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  peptide

<400>  18

Cys Lys Ala Ser Arg Leu Gly Arg Cys 
1               5                   


<210>  19
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  peptide

<400>  19

Cys Arg Gly Ala Ser Met Asp Gly Cys 
1               5                   


<210>  20
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  peptide

<400>  20

Cys Gly Arg Pro Gly Glu Ser Ser Cys 
1               5                   


<210>  21
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  peptide

<400>  21

Cys Ser Arg Thr Glu Gly Asp Val Cys 
1               5                   


<210>  22
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  peptide

<400>  22

Cys Ser Gly Arg Arg Gly Lys Ser Cys 
1               5                   


